Best Macon County Grants for Nonprofits in Alabama

The SAA First Book Award, presented by the Shakespeare Association of America (SAA), honors the legacy of Jerome Singerman and supports early career scholars. This prestigious award recognizes the best monograph with a significant Shakespeare component, published as the first book by a current SAA member between September 1, 2024, and September 1, 2025. The award will be announced during the SAA’s Annual Luncheon, celebrating contributions to Shakespeare studies.

The J. Leeds Barroll Dissertation Prize, awarded by the Shakespeare Association of America, honors exemplary doctoral work with a significant focus on Shakespeare. This prestigious award is conferred annually during the SAA’s Annual Luncheon. To be eligible, applicants must be SAA members in good standing, and dissertations must be approved between September 1, 2024, and September 1, 2025. This prize encourages innovative research and scholarship in Shakespeare studies.

The Barbara Hodgdon Award, presented by the Shakespeare Association of America (SAA), honors exceptional scholarship in the field of Shakespeare and Performance. Established in memory of Barbara Hodgdon, this award encourages innovative research across various media and time periods related to Shakespeare's work. Eligible submissions must be authored by SAA members and published two years prior to the award presentation. This recognition promotes new discussions and insights within the realm of Shakespearean performance studies.

The AΩA Fellows in Leadership Program, established by the Alpha Omega Alpha Honor Medical Society, aims to cultivate leadership skills among mid-career medical professionals. Recipients receive $30,000 to develop a year-long project focused on enhancing their leadership capabilities. This initiative emphasizes servant leadership and innovative thinking, addressing the increasing complexities in healthcare. The program seeks to empower leaders who can effectively navigate the evolving landscape of medicine while promoting the core values of the AΩA society.

U.S. Venture Sponsorships, supported by the Us Venture Schmidt Family Foundation, aim to enhance community engagement by addressing the root causes of poverty through collaboration and social innovation. Grants typically do not exceed $10,000, ensuring that eligible public charities, especially those with 501(c)(3) status, can benefit. Each organization can receive one sponsorship grant annually, reflecting U.S. Venture's commitment to giving back and fostering meaningful partnerships.

The Morris Animal Foundation invites proposals for the Feline Health Fellowship Training Award, aimed at advancing the health and welfare of domesticated cats. This program supports new investigators by providing salary funds in a mentoring environment. Proposals should focus on hypothesis-driven research with high scientific merit, targeting community and pet cats (Felis catus). The maximum award duration is 24 months, with budgets not exceeding $145,000. Join us in making impactful contributions to feline health.

The Morris Animal Foundation offers the Annual Feline Proposals: Feline Health Established Investigator Award to support research aimed at improving the health and welfare of domesticated cats. Established in 1948, the foundation funds innovative, hypothesis-driven studies that demonstrate high scientific merit. This grant encourages collaboration between academia and industry and has a maximum project duration of 36 months, with average awards around $100,000. Eligible proposals should focus solely on domesticated cats, excluding other feline species.

The Morris Animal Foundation offers the Annual Feline Health Pilot Study Award to support innovative research that enhances the health and welfare of domesticated cats. This funding is aimed at proof-of-concept studies, advancing animal health research through collaborative projects. With a maximum funding of $20,000 for a 12-month duration, the foundation seeks proposals that have a significant impact on both scientific and community stakeholders, ensuring a healthier future for feline populations.

The Morris Animal Foundation is dedicated to improving the health of animals through scientific research and funding. With a focus on domesticated cats, the Feline Health First Award supports innovative research that addresses the welfare of both community and pet cats. Grants are available for projects lasting up to 24 months, with a maximum budget of $120,000. This initiative encourages collaborations that translate research findings into practical applications for veterinarians and cat caretakers.

The Alzheimer’s Association Research Grant For All (AARGA) Program supports early-career investigators in their first seven years as independent researchers. This grant aims to fund projects that develop preliminary data and test new hypotheses in Alzheimer’s and related dementia research. Areas of interest include disease mechanisms, biomarker development, and health equity. Applications are welcome from both U.S. and international researchers, fostering innovation and collaboration in the fight against dementia.

The Waldenstrom Macroglobulinemia Fund provides crucial financial assistance to underinsured patients suffering from this rare blood cancer. Through the HealthWell Foundation, the fund helps cover prescription copays, insurance premiums, and treatment-related costs, ensuring access to necessary medical care. With over $1.2 billion in grants awarded, the program has supported more than 1.1 million patients since its inception in 2004. Its mission is to alleviate financial barriers to essential healthcare, allowing patients to focus on their treatment and recovery.

The Systemic Sclerosis with Interstitial Lung Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from systemic sclerosis. This rare autoimmune disease leads to excessive collagen production, causing serious health issues. The fund assists with prescription copays and insurance premiums to ensure patients receive necessary treatments. In 2024, HealthWell awarded over $1.2 billion in grants, supporting more than 1.1 million patients in accessing vital healthcare services.

The Porphyrias Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from porphyrias, a group of eight disorders characterized by the accumulation of porphyrins in the body. The fund assists with prescription drug copays and insurance premiums, offering up to $4,000 in financial aid. Established to ensure no patient lacks necessary treatment due to costs, the foundation has awarded over $1.2 billion since 2004, supporting more than 1.1 million patients.

The ACS - Fanconi Cancer Foundation Discovery Boost Grant invites innovative proposals for translational cancer research addressing the challenges faced by individuals with Fanconi anemia (FA). This grant supports high-risk, high-reward projects aimed at improving detection, prevention, or treatment of FA-related cancers. With funding of up to $135,000 per year for two years, it encourages research in early detection technologies, prevention mechanisms, and therapeutic strategies tailored to the unique sensitivities of the FA population.

The Metabolic Dysfunction-Associated Steatohepatitis Fund, established by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients facing chronic illnesses. It provides critical support for expenses related to prescription copays, insurance premiums, and transportation for treatment. With a maximum award of $8,000, the fund ensures that individuals can access necessary healthcare services without financial strain. This initiative emphasizes the commitment to improving health outcomes for those affected by metabolic dysfunction-associated steatohepatitis.

The Mantle Cell Lymphoma Fund, managed by the HealthWell Foundation, provides financial assistance to underinsured patients diagnosed with Mantle Cell Lymphoma. The fund covers prescription drug copays and Medicare Part B premiums, with a maximum award of $8,500. Eligible patients must have insurance that covers their medication and meet specific income guidelines. The foundation aims to reduce financial barriers to essential treatments, ensuring that patients receive necessary care without undue financial strain.

The HealthWell Foundation's Inborn Metabolic or Genetic Bile Acid Deficiency Vitamins and Supplements Fund provides essential financial assistance for individuals facing significant health challenges. By covering copays, deductibles, and related expenses, the fund aims to alleviate the financial burden on underinsured patients. With a commitment to enhancing healthcare access, the Foundation has awarded over $1.2 billion since its inception, ensuring that vital treatments remain accessible to those in need.

The Hyperoxaluria Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from hyperoxaluria, a condition characterized by excessive oxalate in urine. This fund assists with prescription drug copays and insurance premiums, providing vital support for treatments. In 2024 alone, HealthWell allocated over $1.2 billion in grants, ensuring access to essential medications for those in need. The organization is committed to improving healthcare access and reducing disparities for affected individuals.

The Emergency/Medical Workers Behavioral Health Fund aims to support emergency workers facing trauma and anxiety due to their roles. Established by the HealthWell Foundation, it provides financial assistance for treatment-related costs, including copayments for prescription drugs, counseling, and transportation. In 2024, the Foundation awarded over $1.2 billion to underinsured patients, ensuring no one is denied essential healthcare due to financial barriers. This initiative helps address the critical mental health needs of those who serve on the front lines.

The Dupuytren’s Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from Dupuytren's Disease. This fund provides assistance for prescription drug copays and insurance premiums related to treatment. With an average grant utilization of $1,650 over a 12-month period, the fund ensures that essential medications and therapies are affordable. HealthWell Foundation, a private non-profit, has helped over 1.1 million patients since 2004, demonstrating its commitment to healthcare access.

The Cushing's Disease or Cushing's Syndrome Fund, operated by the HealthWell Foundation, provides vital financial assistance to underinsured patients facing high medical costs associated with these conditions. The fund covers co-payments, insurance premiums, and necessary treatments, ensuring that patients receive the care they need without financial burden. With an average grant utilization of $3,000 over twelve months, this fund aims to alleviate the challenges of treatment accessibility, supporting both physical and mental health for those affected.

The New Music Creator Fund provides financial support to individual music creators across all genres, helping them advance their creative practice. This initiative covers costs associated with developing new work and collaborative projects. Applicants must be at least 21 years old and have three years of professional music experience. The fund aims to empower diverse music creators in the U.S. by facilitating the development of innovative musical ideas and fostering artistic collaboration.

The Music Teachers of Excellence (MToE) Award, managed by the CMA Foundation, recognizes outstanding public-school music educators. This prestigious award, with a $5,000 prize, aims to support teachers who inspire students and enrich their communities through music education. The application will open on September 3, 2025, allowing full-time music teachers with at least four years of experience to showcase their commitment and impact in the field. Stay tuned for more details!

The Special Excellence Annual Scholarship, offered by the CIRI Foundation, supports full-time students in 4-year undergraduate or graduate programs who demonstrate exceptional academic achievements and community service. With awards up to $20,000 for one academic year, this merit-based scholarship emphasizes the importance of maintaining a minimum GPA of 3.7 and encourages contributions to the Alaska Native community. This initiative fosters educational success and economic self-sufficiency among Alaska Natives and their descendants.

The Raven Fund Scholarships, offered by the CIRI Foundation, support educational aspirations for CIRI voting shareholders who are not original shareholders or descendants. Award amounts include $200 per credit for full-time students, up to $3,000 per term, and similar support for part-time students. Funds cover tuition, fees, books, supplies, and housing. Applicants must have a high school diploma, be enrolled in an accredited program, and maintain a minimum GPA of 2.0 to qualify.

The Raven Fund Jump Start Award, established by the CIRI Foundation, provides scholarships of up to $2,000 per year for CIRI voting shareholders who are high school students. Eligible applicants must be enrolled in a recognized post-secondary education program, maintaining a minimum GPA of 2.0. The funding covers direct educational costs such as tuition, books, and housing. The award allows for multiple applications within the year, encouraging ongoing educational pursuits.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.